Art. 1 Decision_act (EU) 1997/348

In forcesince 1 Jan 2000
1.

The Community shall purchase the following strains of foot-and-mouth disease antigen:

–

A22 Iraq: 2 000 000 doses

–

C1: 5 000 000 doses

–

ASIA 1: 5 000 000 doses

1.

up to a maximum cost of ECU 2,4 million.

2.

The antigen mentioned in paragraph 1 shall be supplied by Rhône Mérieux.

3.

The Community shall make arrangements for formulation, production, bottling and distribution of vaccines against foot-and-mouth disease produced from antigens mentioned in paragraph 2 initially up to a maximum cost of ECU 1,5 million.

4.

The action referred to in paragraph 3 shall be organized by the Commission.

Changed on 1 Jan 2000

-— A22 Iraq: 2 000 000 doses -— C1: 5 000 000 doses -— ASIA 1: 5 000 000 doses 1. up to a maximum cost of ECU 2,4 million.

  1. 1 Jan 2000 – todayin force
  2. 23 May 1997 – 1 Jan 2000earlier wording